Nodal-stage classification in invasive lobular breast carcinoma: Influence of different interpretations of the pTNM classification

Journal of Clinical Oncology

Volumn 28, Issue 6, 2010, Pages 999-1004

  Van Deurzen, Carolien H M ^a   Cserni, Gabor ^a   Bianchi, Simonetta ^a   Vezzosi, Vania ^a   Arisio, Riccardo ^a   Wesseling, Jelle ^a   Asslaber, Martin ^a   Foschini, Maria P ^a   Sapino, Anna ^a   Castellano, Isabella ^a   Callagy, Grace ^a   Faverly, Daniel ^a   Martin Martinez, Maria Dolores ^a   Quinn, Cecily ^a   Amendoeira, Isabel ^a   Kulka, Janina ^a   Reiner Concin, Angelika ^a   Cordoba, Alicia ^a   Seldenrijk, Cornelis A ^a   Van Diest, Paul J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SENTINEL LYMPH NODE; BREAST TUMOR; CLASSIFICATION; LUNG CARCINOMA; LYMPH NODE; METASTASIS; PATHOLOGY; PROGNOSIS; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 77949889331     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.0723     Document Type: Article

References (21)

1. Cserni G, Amendoeira I, Apostolikas N, et al: Pathological work-up of sentinel lymph nodes in breast cancer: Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654-1667, 2003 (Pubitemid 36897601)
2. van der Heiden-van der Loo M, Bezemer PD, Hennipman A, et al: Introduction of sentinel node biopsy and stage migration of breast cancer. Eur J Surg Oncol 32:710-714, 2006 (Pubitemid 44276004)
3. van Diest PJ: Histopathological workup of sentinel lymph nodes: How much is enough? J Clin Pathol 52:871-873, 1999
4. Sobin LH WC: International Union Against Cancer TNM Classification of Malignant Tumours (ed 6). New York, NY, Wiley-Liss, 2002
5. Singletary SE, Greene FL, Sobin LH: Classification of isolated tumor cells: Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 98:2740-2741, 2003 (Pubitemid 37509544)
6. Cox CE, Kiluk JV, Riker AI, et al: Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 206:261-268, 2008
7. de Boer M, van Deurzen CH, van Dijck J: Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653-663, 2009
8. Pugliese MS, Beatty JD, Tickman RJ, et al: Impact and Outcomes of Routine Microstaging of Sentinel Lymph Nodes in Breast Cancer: Significance of the pN0(i+) and pN1mi Categories. Ann Surg Oncol 16:113-120, 2009
9. Cserni G, Bianchi S, Boecker W, et al: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103:358-367, 2005 (Pubitemid 40129296)
10. Cserni G, Sapino A, Decker T: Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 15:347-354, 2006 (Pubitemid 43812223)
11. Turner RR, Weaver DL, Cserni G, et al: Nodal stage classification for breast carcinoma: Improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 26:258-263, 2008
12. Roberts CA, Beitsch PD, Litz CE, et al: Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg 186:324-329, 2003 (Pubitemid 38368603)
13. de Mascarel I, MacGrogan G, Debled M, et al: Distinction between isolated tumor cells and micrometastases in breast cancer: Is it reliable and useful? Cancer 112:1672-1678, 2008
14. Cserni G, Bianchi S, Vezzosi V, et al: Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer 44:2185-2191, 2008
15. Rothman KJ: Epidemiology: An Introduction. New York, NY, Oxford University Press, 2002
16. van Deurzen CH, de Boer M, Monninkhof EM, et al: Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 100:1574-1580, 2008
17. Viale G, Maiorano E, Pruneri G, et al: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241:319-325, 2005
18. Bolster MJ, Peer PG, Bult P, et al: Risk factors for non-sentinel lymph node metastases in patients with breast cancer: The outcome of a multi-institutional study. Ann Surg Oncol 14:181-189, 2007 (Pubitemid 44954287)
19. Degnim AC, Griffith KA, Sabel MS, et al: Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 98:2307-2315, 2003 (Pubitemid 37466644)
20. Orvieto E, Maiorano E, Bottiglieri L, et al: Clinicopathologic characteristics of invasive lobular carcinoma of the breast: Results of an analysis of 530 cases from a single institution. Cancer 113:1511-1520, 2008
21. van Deurzen CH, van Hillegersberg R, Hobbelink MG, et al: Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 29:497-505, 2007 (Pubitemid 350136504)